Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance

2025 ICD-10-CM code A30.4

Borderline lepromatous leprosy (BL leprosy).

Use additional code to identify resistance to antimicrobial drugs (Z16.-). Refer to iFrameAI product for updated and complete guideline information

Medical necessity for treatment of borderline lepromatous leprosy is established by confirmation of the diagnosis through clinical findings and diagnostic testing.Treatment is necessary to prevent disease progression, nerve damage, and disability.

Clinicians should assess for sensory loss in the skin over the lesions. Leprosy can present with discolored skin patches, dry or thick skin, nodules on the face and earlobes, painless ulcers on the feet, and loss of eyebrows or eyelashes.In severe cases, nerve damage can cause numbness, muscle weakness, paralysis, and eye problems. Diagnosis is based on symptoms, physical examination, and skin/nerve biopsy. Treatment involves a combination of antibiotics and anti-inflammatory drugs.

In simple words: Borderline lepromatous leprosy is a type of leprosy, a slow-developing bacterial infection. It causes many flat or raised spots, bumps, and dry, flaky patches on the skin. It can last for years and may get better, worse, or change into a different type of leprosy. It affects the nerves, skin, eyes, and inside of the nose.

A form of leprosy, a slow-growing bacterial infection, characterized by numerous flat and/or raised lesions, nodules, and dry, flaky skin (plaques). It may not resolve for years, regress, or progress to other forms. It is caused by Mycobacterium leprae and typically affects the nerves, skin, eyes, and nasal mucosa.

Example 1: A patient presents with multiple skin lesions, some flat and some raised, along with numbness in the affected areas. Biopsy confirms Mycobacterium leprae infection, consistent with borderline lepromatous leprosy., A patient with previously diagnosed borderline tuberculoid leprosy experiences worsening symptoms, with the development of new nodules and increased skin involvement, indicating progression to borderline lepromatous leprosy., A patient presents with numerous flat, discolored patches and dry, flaky skin on their face, arms, and legs, along with some loss of sensation.A skin biopsy confirms Mycobacterium leprae, and the patient is diagnosed with borderline lepromatous leprosy.

Documentation should include the type and distribution of skin lesions, presence or absence of sensory loss, results of skin/nerve biopsies, and any other relevant clinical findings.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.